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Abstract. Axonin-I is a glycoprotein that is released 
from axons of cultured neurons (Stoecldi, E. T., E E 
Lemkin, T. B. Kuhn, M. A. Ruegg, M. Heller, and E 
Sonderegger. 1989. Fur. J. Biochem. 180:249-258). It 
has recently been purified from the ocular vitreous 
fluid of the chicken embryo (Ruegg, M. A., E. T. 
Stoeckli, T. B. Kuhn, M. I-Idler, R. Zuellig, and E 
Sonderegger. 1989. EMBO (Fur. Mol. Biol. Organ.) J. 
8:55-63). Immunohistochemistry localized axonin-1 
prevalently in developing nerve fiber tracts. The pres- 
ence of anti-axonin-1 Fab fragments during axon 
growth in vitro resulted in antibody binding to the ax- 
onal surfaces and in a marked perturbation of the fas- 
ciculation pattern. Hence, a fraction of axonin-1 is as- 
sociated with axonal membranes and, by operational 
criteria, qualifies as a cell adhesion molecule. The 
major proportion f membrane-associated axonin-1 co- 
solubilized with the integral membrane proteins. By 
physico-chemical, immunological, and protein- 
chemical criteria, the integral membrane form was 
found to be highly similar to soluble axonin-1. In com- 
mon with a number of other cell adhesion molecules, 
both soluble and membrane-bound axonin-1 express 
the L2/HNK-1 and the L3 epitopes. Radioactive 
pulse-chase and double-labeling experiments revealed 
that the released form was not derived from the 
membrane-bound form by shedding from the mem- 
brane surface, but directly secreted from an intracellu- 
lar pool. Due to its high degree of similarity to the 
membrane-associated form and the presence of the 
L2/HNK-1 and L3 epitopes, reported to be ligands in 
adhesive cell interactions, adhesive properties are 
postulated for secreted axonin-1. As a soluble adhesive 
protein, it may function as a regulator of cell adhesion 
around its most likely site of secretion, the growth 
cone. 
URING neural development, a variety of interactive 
processes between axons and their cellular and ex- 
tracellular matrix (ECM) ~ environments have be n 
observed. Over the past decade, cell surface xposed glyco- 
proteins with adhesive properties to other cells or the ECM 
have become stablished as one of the dominant molecular 
factors promoting the elongation of axons and/or directing 
them to the target area (for a recent review cf. Rutishauser 
and Jessel, 1988). Proteins ecreted from axons during this 
developmental period have been implicated in a number of 
tasks subserving these goals. Secreted proteases were sug- 
gested to evoke a local weakening of adhesive cell-cell or 
celI-ECM interactions resulting in a terrain favorable for the 
intercalation of the advancing growth cone (Krystosek and 
Seeds, 1981, 1984). A secretory contribution of axons to the 
local construction or reconstruction f the ECM at the site 
1. Abbreviations used in this paper: Ax-CAM, axon-associated a hesion 
molecule; CHAPS, 3-(3-cholamidopropyl)dimethyl-ammonio-l-propane 
sulfonate; DRG, dorsal root ganglia; ECM, extracellular matrix; NILE, 
nerve growth factor-inducible large external glycoprotein; PIB, protease in- 
hibitor buffer. 
of the developing synapse was implied by the observation 
that the specialized synaptic ECM induced the formation of 
postsynaptic specializations in the absence of a presynaptic 
nerve ending (Burden et al., 1979). Such observations have 
entailed a number of studies aiming to identify and purify the 
underlying soluble or extracellularly deposited macromole- 
cules. McMahan and collaborators engaged in the purifica- 
tion of a synaptogenic agent found in extracts of the synaptic 
basal amina of the Torpedo electric organ. On the basis of
its capability o induce the aggregation facetylcholine recep- 
tors on cultured myotubes, they isolated a 95/150-kD doublet 
glycoprotein, which they called agrin (Godfrey et al., 1984; 
Nitkin et al., 1987). Recent findings suggest that, in the 
chick nervous system, agrin-like mol cules are secreted from 
motor neurons (Magill-Solc and McMahan, 1988). Kelly 
and collaborators identified a proteoglycan ofsynaptic vesi- 
cles that is externalized and deposited in the synaptic cleft; 
because of its proposed function, it was termed "terminal an- 
chorage protein" or TAP-1 (Caroni et al., 1985; Carlson et 
al., 1986). Pittman (1985) used an ingenious protease detec- 
tion technique for the identification and characterization f
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proteases in electrophoretically resolved protein mixtures 
and found a plasminogen activator and a calcium-dependent 
metalloprotease among the proteins released from axons of 
cultured neurons. 
In our laboratory, we have chosen the compartmentalized 
cell culture system devised by Campenot (1977) for the 
identification of axonally secreted proteins. Two proteins 
released from axons of embryonic hicken dorsal root gan- 
glion neurons in culture were identified (Stoeckli et al., 
1989). One of them, termed axonin-1, was detected in the 
vitreous humor of the eye and subsequently purified (Ruegg 
et al., 1989). Axonin-1 was found to be predominantly ex- 
pressed uring the second half of embryonic life, concentra- 
tions in the adult being ,020 times lower. To determine the 
functional role of axonin-1, its expression i  the embryonic 
nervous ystem was studied by immunohistochemical tech- 
niques, and perturbation studies with antibodies were car- 
ried out on axons extending from cultured orsal root gan- 
glia. The data reported here identify and characterize a 
membrane-bound homologue of axonin-1 and demonstrate 
its prevalence in nerve fiber tracts. Fab fragments of anti- 
axonin-1 antibodies added to growing axons bind to the ax- 
onal surface and interfere with the formation of axon fasci- 
cles. Based on these observations, the membrane-bound form 
of axonin-1 operationally qualifies as a cell adhesion mole- 
cule. The high degree of structural similarity with membrane- 
bound axonin-1 and the observation that it has structural fea- 
tures in common with established cell adhesion molecules 
suggests that secreted axonin-1 could have adhesive proper- 
ties. Hence, it could represent a regulatory element in cell 
adhesion during neurogenesis. 
Materials and Methods 
Antibodies and Fab Fragments 
Antibodies against axonin-1 were raised in rabbit and goat as previously de- 
scribed (Ruegg et al., 1989). IgG of rabbit immune or nonimmune s ra were 
precipitated with 40% ammonium sulfate at 4°C and further purified by an- 
ion exchange chromatography (Fast Flow Q; Pharmacia Fine Chemicals, 
Uppsaia, Sweden). The purity of the isolated fractions were checked by 
SDS-PAGE. Fab fragments were produced by mercuripapain digestion ac- 
cording to Porter (1959). lab fragments were isolated by cation exchange 
chromatography (mono S; Pharmacia Fine Chemicals). FOr antibody per- 
turbation experiments, Fab fragments were concentrated byultrafiitration 
(diaflo, PM-30; Amicon Corporation, Danvers, MA) and dialyzed against 
Dulbecco's PBS. 
lmmunohistochemistry 
For indirect immunofluorescence localization of xonin-l, 12-vm-thick frozen 
sections were cut from 5.5-d embr~nic spinal cord and 8-d retina (stage 
28 and stage 34, respectively; Hamburger and Hamilton, 1951), fixed in a 
mixture of 2% paraforrnaidehyde and 0.1% glutaraldehyde in 0.1 M sodium 
phosphate, pH 7.4. Goat antiserum against axonin-I was added at a dilution 
of 1:1,000 and incubated for 14 h at 4°C. As a second antibody, FITC- 
conjugated rabbit anti-goat IgG (Zymed Laboratories Inc., San Francisco, 
CA) was added at a dilution of 1:20 and incubated for 90 rain at 21°C. After 
staining, the sections were coverslipped with 90% glycerol, 10% PBS, pH 
8.0, containing 1 my,/ml phenylenediamine, and examined with a fluores- 
cence microscope (Wild and Leitz AG, Zurich, Switzerland) using the L2 
band pass filter set for FITC. 
Cell Cultures 
Dissociated cells from dorsal root ganglia of 10-d chicken embryos were 
cultivated on collagen-coated tissue culture dishes (35 mm in diameter) as 
previously described (Sonderegger et al., 1984). Proliferation of non- 
neuronal cells was minimized by the inclusion of 0.12 mM 5-fluorodeoxy- 
uridine and 0.3 m.M uridine (both from Sigma Chemical Co., St. Louis, 
MO). For pulse-labeling and pulse-chase experiments, a density of 350,000- 
400,000 cells per dish was found to be roost suitable. 
For antibody-induced perturbation f neurite fasciculntion, dorsal root 
ganglia were explanted intosmall droplets of medium containing immune 
or nonimmune Fab fragments at a concentration of 100 pg/mi on a 
polylysine-coated culture dish. After 1 d, when the ganglia bad attached, 
1 ml of culture medium containing mmune or nonimmune Fab fragments 
was added. After 2-3 d in vitro the cultures were washed twice with Dul- 
becco's PBS and fixed with 2.5 % (vol/vol) gluUu'aldehyde in PBS for 30 rain 
at room temperature. The growth pattern of the axons was examined with 
an inverted microscope, equipped with phase contrast optics (diaphot; 
Nikon, Japan). 
To localize the added Fab fragments at the electromnicroscopic level, 
dorsal root ganglia (DRG) were grown on polylysine-coated cover slips 
(thermanox, Lux, Division of Miles Laboratories Inc., Naperville, IL). Af- 
ter 2-3 d, the DRG were washed extensively and fixed with 2.5 % glntaralde- 
hyde in 0.12 M sodium phospbate, pH 7.3, for 30 rain at room temperature, 
rinsed twice with the same buffer, and incubated for 30 rain in a blocking 
solution containing 20 mM lysine in 0.1 M sodium phosphate, pH 7.3. After 
incubation with 0.3% gelatin (type A from porcine skin; Sigma Chemical 
Co.), 10% horse serum (Amimed AG, Basel, Switzerland) in 0.12 M so- 
dium phosphate, pH 7.3 (incubation buffer) for 30 rain, peroxidase-con- 
jugated goat nti-rabbit IgG (Bio-science-products AG, Emmenbriicke, 
Switzerland) was diluted to a final concentration f 24/~g/mi and incubated 
overnight at room temperature. Cultures were washed extensively with the 
incubation buffer (3 x 20 min), followed by three washes with 0.12 M so- 
dium phosphate, pH 7.3. Peroxidase activity was localized by reaction with 
freshly prepared 0.05% (wt/vol) 3,3~iiaminobenzidine-4HCI (Serva Fine 
Biochemicals, Heidelberg, FRG), 0.01% H202 in 100 mM NaCI, 50 mM 
Tris-HCl, pH 7.3. Cultures were postfixed with 1% osmiumtetroxide (Serva 
Fine Biochemicals) for 1 h and treated with 1% uranyl acetate (Merck, 
Darmstadt, FRG) in 50 mM sodium acetate, pH 5 for 2 h at 4°C. Cultures 
were dehydrated and embedded in Epon 812 (Fiuka, Buchs, Switzerland). 
Metabolic Labeling of Cell-bound and Released 
Axonin-1 of Cultured DRG Neurons 
Proteins were metabolically labeled in the presence of 5% horse serum and 
5% chicken embryo extract. For long term labeling, [3H]leucine proved 
less harmful to the cells than [35S]methionine. The medium for [3H]leucine 
labeling was composed of leucine-free growth medium substituted with 
100 #M unlabeled leucine and 0.2 to 0.25 mCi/ml [3H]ieucine. [3H]leu- 
cine, purchased at 1 mCi/ml (New England Nuclear, Boston, MA), was 
dried by vacuum centrifugation (Speed Vac concentrator; Savant, Farming- 
dale, NY) in the presence of a 1/10 vol of MEM (without sodium bicar- 
bonate and L-leucine) and redissolved in a 1/10 vol f H20. The osmolarity 
of this medium was 325 =t: 10 mosM. The concentrated [3H]leucine was 
stored at -70°C until required. For [35S]methionine labeling, the growth 
medium contained 25 ~tM unlabeled amino acid and 0.2-0.25 mCi/ml 
[35S]methionine (New England Nuclear). 
Conditioned media were collected and the cells were washed three times 
with 2 ml of fresh medium. The medium of the first wash step was added 
to the conditioned medium. All solutions were buffered by the addition of 
1/10 vol of 200 mM Hepes, pH 7.2. For the immunoprecipitation f meta- 
bolically labeled axonin-l, 500 pl of vitreous fluid containing ,~1-2 pg of 
unlabeled axonin-l, were added to all conditioned media as a carrier. The 
volume was adjusted to 4.5 ml and the samples were centrifuged at 100,000 g 
for 1 h (50 Ti; Beckman Instruments, Inc., Palo Alto, CA; 40,000 rpm) to 
remove cells and cell debris. For immunoprecipitation, the medium was ad- 
justed to 150 raM NaCI, 5 mM EDTA, 1% (wt/vol) Triton X-100, 50raM 
Tris-HCI, pH 7.5 by the addition of a 10-fold concentrated stock solution, 
and 0.1 ml of rabbit anti-axonin-I antiserum was added. After incubation 
overnight at room temperature, 100 pl of a suspension (1 vol/9 vol) of 
glutaraldehyde-fixed Staphy/ococcus aure in 150 mM NaC1, 5 mM EDTA, 
I% (wt/vol) Triton X-100, 5  mM Tris-HC1, pH 7.5 was added, and incuba- 
tion continued for 2 h at room temperature. Bound antigen-antibody com- 
plexes were released by boiling for 5 rain in 60 pl of SDS-PAGE sample 
buffer. 
For the isolation of cell-bound axonin-l, the washed cells were solubilized 
by the addition of I mi of a solution containing 1% (wt/vol) SDS, 25 mM 
EDTA, 50% (vol/vol) vitreous fluid in Dulbecco's PBS (Ca2+-,Mg2+-free), 
preheated to 90°C in a water-bath. Undissolved material was collected with 
a rubber policeman. The pooled samples were sonicated for 15 min and sub- 
sequently heated in a boiling water bath for 3 rain. To reduce SDS to a con- 
The Journal of Cell Biology, Volume 109, 1989 2364 
centration compatible with antigen-antibody complex formation, the sam- 
ples were diluted with 4 vol of 2% NP-40, 25 mM EDTA, 0.3 M NaCI, 10 
mM sodium phosphate, pH 7.4, and shaken gently for 1 h at room tempera- 
ture. After centrifugation for I h at 100,000 g (50 Ti; Beckman Instruments, 
Inc., 40,000 rpm), the immunoprecipitation was carried out as described 
above, except hat the volumes of the antisera nd Staphylococcus aureus 
suspensions were twice that in the above procedure. 
The immunoprecipitated proteins were separated by SDS-PAGE on 7.5% 
gels. To locate axonin-l, the gels were quickly stained with Coomassie bril- 
liant blue (Serva Fine Chemicals) and a fluorographic replica was made to 
check for the purity of the immunoprecipitation. Fluorography was carried 
out according to the manufacturer's ecommendations, u ing a commer- 
cially available nhancer (En3Hance; New England Nuclear), and exposure 
to medical x-ray films (Fuji, Japan) was for 3 d at -70°C. Protein bands 
corresponding to axonin-I were cut out from the gels, rehydrated, and in- 
cubated for 2 d at room temperature in a mixture of 10 vol of Lipoluma (Lu- 
mac/3M, Schaesberg, The Netherlands), 1 vol of Lumasolve (Lumac/3M), 
and 0.2 vol of water and counted in a liquid scintillation counter (Kontron, 
Zurich, Switzerland). 
External Biotin Labeling of Cultured DRG Neurons 
and AJ~inity Chromatography on Streptavidin-Agarose 
Externally accessible proteins of intact DRG neurons in dissociated culture 
were covalently modified with the amino group-specific reagent biotin-X- 
NHS (Calbiochem-Behring Corp., San Diego, CA) (Hare and Lee, 1989; 
Boxberg, 1987). The conditioned medium was removed, and the cells were 
washed three times with biotinylation buffer (116 mM NaCI, 5.4 mM KCI, 
0.8 mM MgCI2, 1.4 mM CaCI2 in 26 mM sodium bicarbonate buffer, pH 
7.2). The osmolarity was adjusted to 325 mosM by the addition of D-glu- 
cose. A stock-solution of 3 mg/mi biotin-X-NHS in water-free DMSO was 
diluted to a final concentration f 30/~g/ml in biotinylation buffer. Incuba- 
tion with the labeling reagent was for 2 min at 37°C. The reaction was 
stopped by removal of the labeling medium and the addition of 2 ml MEM. 
Biotinylated cells were washed twice with PBS and dissolved in 0.5 ml 
1% (wt/vol) SDS, 5 mM EDTA, 50% (vol/vol) vitreous fluid in Dulbecco's 
PBS (Ca 2+-, Mg 2+- free), preheated to 90°C. The tissue culture dishes 
were rinsed with an additional 0.5 ml of 1.1% NP-40, 5 mM EDTA, 50% 
vitreous fluid in Dulbecco's PBS (Ca 2+-, Mg2+-free). The samples were 
pooled, sonicated, heated for 3 min in a boiling water bath, and stored at 
-70°C until required. 
Biotinylated proteins were isolated by affinity chromatography on Strepta- 
vidin-agarose. The solubilized cellular proteins were c ntrifuged at100,000 g 
for I h and subsequently incubated for 16 h at room temperature with 100 t~l 
of a suspension of Streptavidin-agarose (Sigma Chemical Co.). After cen- 
trifugation, removal of the supernatant (unbound fraction), and extensive 
washing of the gel with 150 mM NaCI, 5 mM EDTA, 1% (wt/vol) Triton 
X-100, 50 mM Tris-HCl, pH 7.5, biotinylated proteins were eluted with 1 ml 
of 1% (wt/vol) SDS, 25 mM EDTA, 50% vitreous fluid in Dulbecco's PBS 
(Ca 2+-, Mg 2+- free). To reestablish conditions permissive for antigen-anti- 
body complex formation, 4 ml of 2% (wt/vol) NP-40, 25 mM EDTA, 0.3 
M NaCI, 10 mM sodium phosphate, pH 7.4 were added to the eluted mate- 
rial. Both the bound and the unbound fraction were subjected to immuno- 
precipitation and quantification f the radioactivity incorporated into axon- 
in-l, as described above. 
As a control for the protection of intracellular proteins, biotinylation of 
cytosolic aspartate minotransferase was assessed using the same protocol 
as for axonin-l. Polyclonal rabbit antiserum against cytosolic aspartate mi- 
notransferase and pure chicken cytosolic aspartate minotransferase, used 
as a carrier, were provided by Dr. H. Gehring. 
Preparation and Subfractionation f Brain Membranes 
Brain membranes from 10-14-d-old chicken embryos were prepared ac- 
cording to Hoffman et al. (1982). Brains were removed and washed at 4°C 
in 137 mM NaCI, 2.7 mM KCI, 8.1 mM Na2HPO4. 1.5 mM KH2PO4, 1 
mM CaCI2, 1 mM MgCI2, pH 7.4. For homogenization a d all the follow- 
ing centrifugation steps, a mixture of protease inhibitors (all from Sigma 
Chemical Co.) was added to a final concentration f 0.5 mM PMSE 5/tM 
pepstatin A, 10 I~M leupeptin, and 1% (vol/vol) aprotinin (protease inhibitor 
buffer, PIB). Tissue disruption was carried out using a Dounce homogenizer 
with six strokes of the loose and three strokes of the tight pestle. After cen- 
trifugation for 15 rain at 40,000 g (SS-34; Sorvall Instruments Div., New- 
ton, CT; 20000 rpm), the volume of the pellet was measured and 2 vol of 
2.25 M sucrose in PIB were added. The suspension was placed in centrifuge 
tubes and each aliquot was overlaid with 1/3 vol of 0.8 M sucrose. After 
centrifugation at 100,000 g (%865; Sorval Instruments Div., 38,000 rpm) 
for 1 h, the material at the interface was collected, washed twice, and 
resuspended in PIB. After determination f the protein concentration, buffer 
was added to give a final protein concentration f ,,o 25 mg/ml. All proce- 
dures were carried out at 4°C; if not used immediately, the membrane sus- 
pension was stored at -70°C. 
Before membrane subfractionation, soluble axonin-1, sequestered in mem- 
brane vesicles, was released by sonication in an ice-hath (Kreibich and 
Sabatini, 1974) using a sonifier equipped with a microtip (sonifier 250; 
Branson Sonic Power Co., Danbury, CT). Sonication was carried out in five 
periods of 20 pulses (40 watts, 0.5 s) allowing l-rain intervals for cooling. 
Sonicated membranes were isolated by centrifugation at 100,000 g for 1 h 
at 4°C. To solubilize peripherally adhered proteins, membranes were con- 
secutively exposed to mild and harsh release conditions. Protein release un- 
der mild conditions was in 1 M NaCI in PIB for 90 min at 4°C, followed 
by centrifugation at 100,000 g for I h at 4°C. Release under harsh conditions 
was at high pH (Steck and Yu, 1973). In using a buffered solution we fol- 
lowed the suggestion ofFujikl et ai. (1982), however, 50 mM triethylamine, 
pH 11.5, was preferred to sodium carbonate (Snow et al., 1988). Incubation 
in 50 mM triethylamine, pH 11.5, in the presence of the protease inhibitors, 
was for 90 rain at 4°C, and a centrifugation at 100,000 g for 1 h at 4°C fol- 
lowed. The pellet of the stripped membranes was resuspended bythe addi- 
tion of PIB to a final protein concentration between 2-4 mg/ml. Extraction 
of membrane proteins was carried out by the addition of I vol of 2 % (wt/vol) 
3-(3-cholamidopropyl)dimethyl-ammonio-l-propane suifonate (CHAPS) in 
PIB with gentle shaking for 90 rain at 4°C. Undissolved material was re- 
moved by centrifngation at100D00 g for I h at 4°C and solubilized in hot SDS. 
ImmunoaJ~nity Chromatography of Axonin-1 
For isolation of the integral membrane form of axonin-l, CHAPS-solu- 
bilized proteins of stripped brain membranes were passed through immuno- 
affinity columns with immobilized rabbit polyclonal anti-axonin-I IgG 
(CNBr-activated Sepharose; Pharmacia Fine Chemicals; containing ,'~5 mg 
of IgG per milliliter packed gel). After binding, the columns were washed 
with at least 40 column vol of 1% CHAPS, 300 mM NaCI, 2.7 mM KCI, 
8.1 mM Na2HPO4, 1.5 mM KH2PO4, 1 mM CaCI2, 1 mM MgCI2, pH 7.4 
including the mixture of protease inhibitors. Bound antigen was eluted with 
50 mM diethylamine, 0.5% CHAPS, pH 11.5. The eluate was neutralized 
immediately by the addition of 1/10 vol of 1 M Tris-HCl, pH 7.0. All proce- 
dures were carried out at 4°C. 
Protein Determinations 
Concentrations of soluble protein in the range of 0.2-1.2 mg/ml were deter- 
mined according to Bradford (1976), using a commercially available product 
(Bio-Rad Protein Assay; Bio-Rad Laboratories, Richmond, CA). Protein of 
brain membrane suspensions was quantified using a modification of the 
Bradford procedure adapted for measurements in the presence of SDS 
(Rubin and Warren, 1977). Lower protein concentrations were determined 
after modification with fluorescamine (Fluram; Roche, Basel, Switzerland) 
as described by B6hlen et al. (1973). BSA was used as a standard. 
Electrophoretic Procedures 
SDS-PAGE was carried out according to Laemmli (1970). Two-dimensional 
SDS-PAGE was performed according to O'Farrell (1975) under previously 
detailed conditions (sonderegger t al., 1985). For fluorography (Bonner 
and Laskey, 1974), a commercially available acetic acid-based enhancer 
(En3Hance; New England Nuclear) was used. Silver staining was accord- 
ing to Switzer et al. (1979) as modified by Oakley et al. (1980). Radioactive 
molecular mass markers were the ['4C]methylated forms of cytochrome c 
(12 kD), carbonic anhydrase (30 kD), albumin (69 kD), phosphorylase (97 
kD), and myosin (200 kD) (all from New England Nuclear and mitochon- 
driai aspartate aminotransfemse (45kD) alkylated with [ 14C]N-ethylmale- 
imide; for silver stained gels, cytochrome c (12 kD), carbonic anhydrase 
(30 kD), ovaibumin (45-46 kD), albumin (69 kD), phosphorylase (97 kD), 
~galactosidase (116 kD), myosin (200 kD) (all from Sigma Chemical Co.) 
were used. In some gels (Fig. 3, A and B), the marker proteins were sup- 
plemented with RNA polymerase (Pierce Chemical Co., Rockford, IL) dis- 
playing subunit bands at 165, 155, and 39 kD. 
Peptide Mapping and Deglycosylation 
Peptide mapping of soluble and membrane-associated xonin-I was carried 
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out as described by Cleveland (1983). In brief, 5 ttg of axonin-I were sepa- 
rated by SDS-PAGE on a 5% gel. After visualization of protein bands by 
a short staining with Coomassie blue, axonin-I bands were cut out of the 
gel and equilibrated in 0.1% (wt/vol) SDS, 1 mM EDTA, 10% (vol/vol) 
glycerol, 0.3% (vol/vol)/~-mereaptoethanoi, 125 mM Tris-HCl, pH 6.8 for 
1 h. The gel pieces containing axonin-I were loaded on a SDS-PAGE gra- 
dient gel (10-17.5 % acrylamide). For partial proteolytic digestion during 
electrophoresis, endoproteinase GIu-C (EC 3.4.21.19, from Staphylococcus 
aureus VS; Boehringer Mannheim GmBH, FRG) was added at either 0.1% 
or 0.5% (wt/wt). To enhance proteolysis, electrophoresis was stopped for 
10 rain when the proteins were most concentrated at the intcrphase between 
stacking and separating gel. The resulting peptide fragments were visual- 
ized by silver staining. 
For the nzymatic deglycosylation with glycopeptidase F (peptide N-gly- 
cohydrolase E EC 3.2.2.18, from Flavobacteriwn meningosepticum; Boehr- 
inger Mannheim), 3/~g of soluble or membrane-bound axonin-1 were precipi- 
tated in chloroform/methanol OVessei and Flungge, 1984), and redissolved in
1% SDS, 5% /~-mercaptoethanol, 50 mM EDTA in 20 mM sodium phos- 
phate, pH 7.2, preheated to 90°C. After dilution of the sample to 0.2% SDS, 
1% ~-mereaptoethanol, Triton X-100 was added to give a final concentration 
of 1% (wt/vol) Triton X-100. Deglycosylation was started by the addition of 
1 U of glycopeptidas¢ E Incubation was at 37°C for 24 h. 
Immunoblotting 
Proteins were r solved by one- or two-dimensional SDS-PAGE. Electro- 
transfer onto nitrocellulose (Schleicher and Schuell, Dassel, FRG) was car- 
tied out according to Towbin et al. (1979) at 40 V for 16 h and 4°C. Im- 
munodetection f antigens was performed as described by Hawkes et al. 
(1982). To increase the sensitivity when monocional antibodies were used, 
a modified procedure involving a bridge antibody between the antigen-specific 
and the peroxidase-conjugated ntibody was applied. After incubation of the 
antigen-specific monoclonal antibodies overnight at 4°C, an affinity-purified 
antibody against mouse IgG (goat anti-mouse IgG; Kirkegaard & Perry 
Laboratories Inc., Gaithersburg, MD) was incubated at  concentration f 5 
/tg/ml for 6 h at room temperature. Subsequently, a peroxidase-conjngated n- 
tibody against goat IgG (rabbit anti-goat IgG, peroxidase conjugated; Bio- 
science-products AG) was added and the incubation carried on overnight at 
4°C. The peroxidase-reaction waswith 0.01% H202 (Fluka AG, Buchs, Swit- 
zerland), 0.5 mg/ml 4-chloro-naphthol (E. Merck, Darmstadt, FRG), 200 
mM NaCl in 50 mM Tris-HCI, pH 7.4. The reaction was stopped by washing 
the nitrocellulose with distilled water. Antisera gainst axonin-l, raised in rab- 
bit or goat, were diluted 1/4,000, and monoctonal ntibodies from ascitic 
fluids were diluted 1/1,000. HNK-I was used as the undiluted culture superna- 
rant of the mouse-mouse hybridoma (ATCC TIB 200; American "Pype Cul- 
tore Collection, Rockville, MD). L2 and L3 were used as the undiluted cul- 
tore supernatants ofrat-mouse bybridomas (provided by Dr. M. Schachner). 
Polyclonal rabbit IgG against N-CAM and Ng-CAM (provided by Dr. G. M. 
Edelman and coworkers) were used at a concentration f 20 #g/ml. Polyclonal 
lgG against G4, FI 1, and neurofascin (provided by Dr. E Rathjen and cowork- 
ers) were used at a concentration f 25 #g/ml. 
Ouchterlony Double Diffusion Test 
For the Ouchterlony double diffusion-in-gel technique (Nilsson, 1983), 1.5% 
agarose in PBS was heated to 95°C and poured onto 20 x 65-ram glass slides 
to a thickness of 3 mm. After congelation, the coated slides were stored in 
a humid chamber at 4°C. Immediately before use, 3-ram-wide circular basins 
were punched out and filled with antigen or antiserum solutions. Incubation 
was for 48 h at 4°C. 
ELISA 
ELISA was performed as previously described (Ruegg et al., 1989). All 
measurements were carried out in 300 mM NaCI, 5 mM EDTA, 1% Triton 
X-100, or 1% CHAPS, 50 mM Tris-HCl, pH 7.5. The concentration of
axonin-1 used for the calibration curves of ELISAs was determined by mea- 
surement of the absorption at 220 nm (EmM ---- 1,850, as determined by 
amino acid analysis). The results obtained by ELISA were in good agree- 
ment with the estimations based on immunoprecipitation, f llowed by SDS- 
PAGE and silver staining, where the relative intensity of axonin-I was deter- 
mined by comparison with a dilution series of a known quantity of pure 
axonin-1. 
Results 
Axonin-l-like Immunoreactivity Is Associated with 
Developing Nerve Fiber Tracts 
To localize axonin-1 in developing central nervous tissue, 
cryostat sections of aldehyde-fixed tissue were subjected to 
indirect immunofluorescence staining. In 5.5-d embryonic 
chicken retina, the optic fiber layer was intensely stained, 
weaker staining of diffuse appearance was found in the de- 
veloping inner plexiform layer (Fig. 1, A and C). In 8-d em- 
bryonic spinal cord, axonin-l-like immunoreactivity was 
most intense in the dorsal funiculus, weaker staining oc- 
curred in the dorsal roots and the dorsal root ganglia (Fig. 
1, B and D). No fluorescence was detected with preimmune 
serum used at the same dilution (Fig. 1, E and F). With 
monoclonal antibodies against axonin-1, the same staining 
pattern was obtained (not shown), hence, a specific axonin- 
l-like immunoreactivity was involved. 
Predominant association with nerve fiber tracts is typically 
found with a group of adhesive glycoproteins, termed axon- 
associated adhesion molecules (AxCAMs), because oftheir 
topographic restriction to axonal membranes of nerve fiber 
tracts (Rutishauser and Jessel, 1988). In the retina, the stain- 
ing pattern of axonin-1 was virtually identical to that reported 
for Ng-CAM (Thiery et al., 1985; Daniloffet. al, 1986), G4 
(Rathjen et al., 1987a), and 8D9 (Lemmon and McLoon, 
1986), whereas the reported immunoreactivity of neurofas- 
cin is distinct from axonin-1 by its confinement tothe inner- 
most part of the optic fiber layer (Rathjen et al., 1987b). In 
the spinal cord at embryonic day 5 or 6, the immunoreac- 
tivity for axonin-1 is virtually restricted to the dorsal funicu- 
lus, whereas the r ported immunoreactivity pattern for Ng- 
CAM (Thiery et al., 1985; Daniloff et al., 1986) and (34 
(Rathjen et al., I987b) also includes the white matter of the 
ventral horn. The distribution of neurofascin i  the spinal 
cord was reported to be even more widespread, including the 
dorsal and ventral funiculus and the ventral commissure 
(Rathjen et al., 1987b). 
Fab Fragments of Anti-Axonin-1 Antibodies Bind to 
Growing Axons and Perturb Their Fasciculation 
As a first step in the investigation on a functional role of 
axonin-1 in cell adhesion, an antibody perturbation assay of 
axon fasciculation was chosen. The specificity of the poly- 
clonal rabbit antibodies used has been documented under a 
variety of conditions (Ruegg et al., 1989; this paper); of par- 
ticular pertinence, no reactivity to proteins in the molecular 
weight range of the chicken cell adhesion molecules involved 
in axon fasciculation was detectable with these antibodies by 
immunoaffinity chromatography of brain membrane proteins 
under native conditions (see Fig. 3 A, lane/). In all of eight 
independent perturbation experiments, the presence of 
anti-axonin-1 Fab fragments in the medium of dorsal root 
ganglia cultures during the period of axon extension had a 
dramatic impact on the axonal growth pattern (Fig. 2). 
Axons grown in the absence of antibodies formed fascicles 
with obvious radial orientation (Fig. 2 B). The presence of 
Fab fragments during axon elongation resulted in a fine 
meshwork of relatively thin fascicles (Fig. 2 A); most nota- 
bly, the radial orientation of the axon fascicles, observed un- 
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l~gure L Immunohistochemistry localizes axonin-I in erve fiber tracts. Aldehyde-fixed frozen sections of 8-d-old embryonic retina (A, 
C, and E) and 5.5 d-old embryonic spinal cord (B, D, and F) were subjected to indirect immunofluorescence staining using anti-axonin-1 
antiserum and FITC-conjugated second antibodies. A and B, phase optics. C and D, anti-axonin-1 antiserum. The arrows in C indicate 
the optic fiber layer (OFL) and the inner plexiform layer (IPL), respectively. The arrows in D indicate the dorsal funiculus (DF) and the 
dorsal root ganglion (DRG), respectively. E and F, controls with preimmune serum at the same dilution as immune serum. Bars: (A, C, 
and E) 60 tLm; (B, D, and F) 150 #m. 
der standard culture conditions, had virtually disappeared.. 
At higher magnification (Fig. 2, C and D), a markedly finer 
texture of the axonal meshwork (Fig. 2 C) was the most obvi- 
ous effect observed when axons were grown in the presence 
of anti-axonin-1 Fab fragments. A reduction of the fascicle 
diameter was less striking, yet clearly reproducible. If thin 
fascicles at the periphery of the ganglia were inspected, an 
increased tendency of single fibers to branch off their fasci- 
cle was obvious. 
The ultrastructural location at the end of a perturbation ex- 
periment of the added Fab fragments was determined by im- 
munoelectron microscopy using a peroxidase-conjugated 
second antibody (Fig. 2, E and F). Intense staining of axonal 
membranes in axon fascicles was found (Fig. 2 E), suggest- 
ing a membrane-bound form of axonin-I as the site of action 
in perturbing fasciculation. 
Membrane-associated Axonin-1 Comprises a Major 
Integral Membrane Protein and a Minor Peripheral 
Membrane Component 
The nature of membrane association of axonin-I was inves- 
tigated on sonicated brain membranes prepared from 14-d- 
old chick embryos by consecutive xposure to selected re- 
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Figure 2. Anti-axonin-I Fab fragments bind to axonal membranes and perturb neurite fasciculation. Dorsal root ganglia were cultured 
in the presence of 100/~g/ml of anti-axonin-I Fab fragments (A, C, and E) or Fab fragments isolated from nonimmune sera, respectively 
(B, D, and F). After 2 d in culture, cells were fixed with 2.5 % glutaraldehyde and the growth pattern of axons was examined on an inverted 
microscope, equipped with phase contrast optics. A and C, axon growth pattern obtained in the presence of Fab fragment  against axonin-l. 
Note the virtual absence of a clear radial orientation (A)and the fine texture of the axonal meshwork (C). B and D, axon growth pattern 
in the presence of nonimmune Fab fragments. Note the thicker fascicles with predominantly radial orientation (B) and the coarse texture 
of the axonal meshwork (D). E and F, immunoelectron microscopic localization of Fab fragments at the end of a perturbation experiment. 
E, axons grown in the presence of anti-axonin-1 Fab fragments. F, axons grown in the presence of nonimmune Fab fragments. Bars: (A 
and B) 200/Lm; (C and D) 40 ~m; (E and F) 0.25 ~m. 
lease conditions (TaMe I). The high-salt and the high-pH 
procedures together emoved 37 % of the axonin-1. About 
two-thirds of the membrane-bound axonin-1 were refractory 
to extraction by high salt and high pH, but were solubilized 
in the presence of CHAPS, and hence, by operational defini- 
tion, are integral membrane protein. No axonin-I was found 
among the remaining proteins that could only be solubilized 
by hot SDS. 
The highest specific concentration of axonin-1 was deter- 
mined in the CHAPS-extractable fraction. Specific concen- 
trations in the high-salt and high pH-extracted fractions were 
lower by a factor of five and twelve, respectively. Obviously, 
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Table L Subfractionation f Brain Membrane-associated 
Axonin-1 
Protein Axonin-I Specific concentration of
Solubilization in supernatant in supernatant axonin-i in superoatant 
mg izg % ng/mg protein 
Total 907 73 100 - 
1 M NaC1 91 9 12 99 
pH 11.5 425 18 25 42 
1% CHAPS 91 46 63 506 
1% SDS 300 <0.1 <0.1 <0.3 
Brain membranes from 14-d-old chicken mbryos were resuspended at a pro- 
tein concentration of 27 mg/ml. Soluble axonin-1 enclosed in membrane vesi- 
cles (14 /~g) was released by sonication. The sonicated membranes were 
consecutively exposed to I M sodium chloride, to50 mM triethylamine, pH 
I 1.5, to ! % CHAPS, and to 1% SDS. After each step of this sequence, mem- 
branes were centrifuged for 1 h at 100,000 g at 4°C and the concentration of 
protein and axonin-1 determined in the supernatant; the pellet was resuspended 
in the appropriate solution for the next step. Quantification of axonin-I was 
performed with ELISA, except for the SDS fraction, where immunoprecipita- 
tions using polyclonal rabbit anti-axonin-I antibodies and glutaraidehyde-fixed 
Staphylococcus aureus were carried out after dilution to0.2 % SDS and the ad- 
dition of Triton X-100 to a sixfold excess (wt/vol) over SDS. Precipitates were 
subjected to SDS-PAGE and silver staining, and the bands corresponding to 
axonin-I were quantified with a series of purified axonin-I standards. The same 
immnnoprecipitation procedure was also used for a validation of the ELISA 
data. The proportions f axonin-I in the vesicular, peripheral membrane, and 
integral membrane protein fractions were in close agreement with those deter- 
mined by ELISA. 
the surface-bound and the integral membrane proteins are 
populations of markedly distinct composition. Furthermore, 
the 12-fold higher specific concentration f axonin-1 in the 
integral membrane protein fraction as compared with the 
high pH-released proteins clearly indicates that axonin-1 
found in the integral membrane fraction does not represent 
a contamination due to incomplete r moval of the surface ad- 
sorbed proteins. 
Axonin-1 of the Integral Membrane Protein Fraction Is 
Highly Similar, Yet Not Identical, to Soluble Axonin-1 
The high-salt and high pH-resistant form of axonin-1 ex- 
tracted from stripped membranes by 1% CHAPS in the pres- 
ence of protein inhibitors migrated slightly faster in SDS-PAGE 
on a 7.5 % gel and its relative molecular mass was estimated 
to be 128 kD, i.e., "~2 kD lower than the relative molecular 
mass of its soluble counterpart (Fig. 3 A). Digestion with 
glycopeptidase F resulted in a reduction of the apparent mo- 
lecular mass by ,x,15 % in both soluble and membrane-bound 
axonin-1 (Fig. 3 B). The estimated relative molecular mass 
of deglycosylated membrane-bound axonin-1 was 115 kD, 
that of the soluble form •117 kD. Hence, a molecular mass 
difference of 2 kD was also present after enzymatic removal 
of N-linked carbohydrate. 
Several pieces of evidence indicate that he soluble and the 
integral membrane forms of axonin-1 are highly similar pro- 
teins. (a) A comparison by means of the Ouchterlony double- 
diffusion test revealed immunological identity, as indicated 
by the complete fusion of the precipitin lines (Fig. 3 C). (b) 
Soluble and membrane-bound axonin-1 are also indistin- 
guishable with respect to the number and the pI of their iso- 
electric variants, as revealed by two-dimensional SDS-PAGE 
(not shown). (c) The peptide maps generated by partial pro- 
teolytic leavage according to Cleveland (1983) add further, 
independent evidence for a high degree of similarity between 
the soluble and the integral membrane forms of axonin-1. As 
demonstrated in Fig. 3 D, 26 peptides between 140 and 13 
kD resulted from partial proteolytic cleavage with endopro- 
t inase Glu-C, 25 peptides being present in both samples. 
One peptide of'~ 22 kD (arrow in Fig. 3/9) was only discern- 
able in the maps derived from membrane-bound axonln-1. 
Axonin-1 Is Distinct from other Adhesive 
Giycoproteins of the Nervous System 
Axonin-1 was compared with the neuronal cell adhesion 
molecules of the chicken reported to be associated with neu- 
ronal membranes of nerve fiber tracts and involved in axon 
fasciculation, amely N-CAM, Ng-CAM, (34, Fll, and neu- 
rofascin (Fig. 4). A comparison with Ng-CAM and N-CAM 
is shown in the upper three sections of Fig. 4. Both the solu- 
ble and the integral membrane form of axonin-1 showed 
strong reactivity with polyclonal anti-axonin-1 (Fig. 4 A). A 
strongaxonin-1 immunoreactive band was revealed in the 
vitreous fluid of the eye, whereas the axonin-l-reactive com- 
ponent of the stripped brain membranes was only repre- 
sented by a relatively faint band. Neither polyclonal anti-Ng- 
CAM nor polyclonal anti-N-CAM recognized either form of 
axonin-1 (Fig. 4, B and (7, respectively). With polyclonal 
anti-Ng-CAM (Fig. 4 B, lane BM) and anti-N-CAM anti- 
bodies (Fig. 4 C, lane BM) strong immunoreactivity with 
abundant protein bands of the molecular mass expected for 
Ng-CAM (Grumet et al., 1984) and N-CAM (Rothbard et 
al., 1982; Daniloff et al., 1986), respectively, were detected 
in brain membranes and faint immunoreactivity at the same 
migratory distance was also observed in the vitreous fluid. 
The immunoblot analysis for immunological cross-reac- 
tivity of axonin-1 with G4, FII, and neurofascin s shown in 
the lower three sections of Fig. 4. None of the polyclonal an- 
tisera against (34 (D), Fll (E), and neurofascin (F) showed 
cross-reactivity with soluble axonln-1 or its membrane-bound 
homologue. Again, as a positive control, the staining pattern 
of the corresponding immunogen was determined, however, 
the purified immunogen was used. In all three cases, the ob- 
tained band pattern was identical with that reported in the 
literature (for G4 and Fll cf. Rathjen et al., 1987a; for neu- 
rofascin cf. Rathjen et al., 1987b). 
Axonin-1 Has the L2/HNK-1 and the L3 Epitopes in 
Common with other Adhesive Glycoproteins 
A typification of axonin-1 for adhesion molecules pecific 
carbohydrate structures (Kruse et al., 1984; Kiicherer et al., 
1987) revealed expression of the L2/HNK-1 as well as the L3 
epitope on both the soluble and the membrane-bound forms 
(see Fig. 5, for an illustration). Two-dimensional SDS-PAGE/ 
immunoblotting further demonstrated the presence of the 
L2/HNK-1 epitope on all the isoelectric variants (Fig. 5 B). 
Pulse-labeling and Pulse-Chase Experiments Reveal 
Two Ceil-associated Forms of Axonin-l, One with Fast 
and One with Slow Turnover 
As a primary step to address the question whether soluble 
axonin-1 was derived from the membrane-bound form or in- 
dependently secreted, the turnover of cellular axonin-1 of 
cultured neurons was determined by pulse-labeling and 
pulse-chase experiments (Fig. 6). Preliminary experiments 
yielded evidence for a rapidly and a slowly saturating form 
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Figure 3. The soluble and the integral membrane forms of axonin-1 are very similar, but not identical. Soluble axonin-I (Axs) was purified 
from the vitreous fluid of El4 chicken embryos; the integral membrane form of axonin-1 (Axm) was isolated from stripped brain mem- 
branes of 14-d-old chicken embryos by CHAPS solubilization in the presence of protease inhibitors and immunoaflinity chromatography. 
A, a comparison of apparent molecular mass of Axs and Axm. SDS-PAGE, 7.5% with silver staining. Lane 1, 0.25 t~g Axm; lane 2, 0.25 
#g Axe; lanes M, molecular mass markers. B, a comparison of the apparent molecular mass of Axs and Axm after enzymatic removal of 
N-linked glycans using glycopeptidase E 5% SDS-PAGE followed by silver staining. Lanes 1 and 5, Axm and Axs, respectively; lanes 2 
and 4, N-deglycosylated Axm and Axs, respectively; lane 3, eomigration of N-deglycosylated Axm and Axe; lanes M, molecular mass 
markers. C, Ouchterlony double diffusion-in-gel test forimmunological comparison ofsoluble and membrane-bound axonin-l. Well 1 con- 
tains 30 t~l of rabbit anti-axonin-1 antiserum at a dilution of 1:10. 30 tzl of Axm (70 tzg/ml) was added to well 2 at the beginning and after 
12 and 24 h of incubation. Axs was added to well 3 in three portions as for the integral membrane form. Note the complete fusion of 
the precipitin lines. Absence of spurs was verified by microscopic nspection using dark field optics with a stereomicroscope (MS, Wild- 
Leitz). D, peptide maps of Axs and Axm according to Cleveland (1983). Lane 1, undigested Axm; lane 2, Axm digested with 0.5% of en- 
doproteinase GIu-C; lane 3, Axs digested with 0.5% of endoproteinase GIu-C; lane 4, Axm digested with 0.1% of endoproteinase GIu-C; 
lane 5, Ax~ digested with 0.1% of endoproteinase GIu-C; lane 6, undigested Axe. All peptides generated from Ax~ are also present in Axm; 
one additional peptide band occurs only in the cleavage product of AXm (arrow). 
The Journal of Cell Biology, Volume 109, 1989 2370 
Figure 4. Axonin-1 is immuno- 
logically distinct from other axon- 
associated cell adhesion molecules 
of nerve fiber tracts. (A, B, and 
C) The cross-reactivity of puri- 
fied soluble and membrane-bound 
axonin-1 with polyclonal antibod- 
ies against N-CAM and Ng-CAM 
was investigated by immunoblot 
analysis; as positive controls, the 
immunoreactivity of the antibod- 
ies with membrane preparations 
was determined. Identical sets of 
proteins (lanes 1-4 of each sec- 
tion) were subjected to 7.5% SDS- 
PAGE followed by electrotransfer 
onto nitrocellulose. Reactivity 
with polyclonal antibodies against 
axonin-1 (A), Ng-CAM (B), and 
N-CAM (C) was visualized with 
peroxidase-conjugated second an- 
tibodies, lane I, rF,, 100 txg of vitre- 
ous fluid proteins; lane Ax,, 0.2 
t~g of soluble axonin-1, purified 
from vitreous fluid of the chicken 
embryo; lane Axm, ([2 t~g of mem- 
brane-bound axonin-l, isolated by 
immunoaltinity chromatography; 
lane BM, 100 txg of CHAPS- 
extracted brain membrane pro- 
teins. Note the prevalence of ax- 
onin-I inthe vitreous fluid, where 
only trace amounts of Ng-CAM 
and N-CAM are found. Both Ng- 
CAM and N-CAM are clearly 
predominant in the brain mem- 
branes, where only a minor band 
of axonin-1 is found. (D, E, and 
F) The cross-reactivity of puri- 
fied soluble and membrane-bound 
axonin-I with polyclonal antibod- 
ies against G4, F11, and neurofas- 
tin was investigated by immuno- 
blot analysis. Purified G4, Fll, 
and neurofascin were used as positive controls. (D) Test for cross-reactivity of soluble and membrane-bound axonin-1 with polyclonal anti- 
bodies against G4. Lane Ax3, 0.2 t~g of soluble axonin-1; lane ,,Ix,, 0.2/~g of membrane-bound axonin-1; lane G4, purified G4 glycopro- 
tein. (E) Test for cross-reactivity of soluble and membrane-bound axonin-1 with polyclonal antibodies against Fll. Lane Ax,, 0.2 tLg of 
soluble axonin-1; lane Axm, 0.2 #g of membrane-bound axonin-l; lane F/l, purified Fll glycoprotein. (F) Test for cross-reactivity of solu- 
ble and membrane-bound axonin-1 with polyclonal antibodies against neurofascin. Lane Ax,, 0.2 #g of soluble axonin-l; lane Axm, 0.2 tLg 
of membrane-bound axonin-l; lane Nf, purified neurofascin. 
of cell-associated axonin-1, the slowly saturating form re- 
quiring several days to incorporate a reasonable quantity of 
radioactive amino acid. The turnover ates, thus, were deter- 
mined by standard decay kinetics after an extended period of 
labeling. Two populations of axonin-1 were found, as 
reflected by biphasic kinetics of the decrease of radioactive 
axonin-1 after the end of the pulse (Fig. 6). Using the data 
of three independent experiments, half-lives of 5.1 h (SEM 
= 0.4, n = 3) and 104 h (SEM = 11, n = 3), respectively, 
were calculated. Data from decay kinetics being prone to er- 
ror introduced by isotope reuse (Schimke, 1975), the half-life 
of the fast-turnover form was also determined by the "ap- 
proach to equilibrium method; which, for theoretical rea- 
sons, is not affected by isotope reuse (Bradley et al., 1976). 
Only a relatively small discrepancy (t~/z = 4.4 h) was ob- 
tained, hence, tracer reuse was concluded to represent a
negligible problem in this dissociated cell culture system. 
The relative size of the two pools was determined by ex- 
trapolation to the beginning of the chase. At this point, when 
both forms are maximally labeled, the radioactive label is 
equally distributed between the two kinetic forms. Since, af- 
ter a pulse of 6 d, the fast-turnover pool is fully labeled, 
whereas the slow-turnover pool (tt/2 = 104 h) is labeled to 
'~70%, the estimated size of the slow-turnover pool exceeds 
that of the fast-turnover pool by a factor close to 1.5. 
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Figure 5. Both membrane-associated and soluble axonin-I bear the L2/HNK-1 epitope, which has been proposed as a marker for cell adhe- 
sion molecules. (A) Immunoblots with monoclonal antibody HNK-1. lane 1, 100 #g of proteins from vitreous fluid; lane 2, 0.2 #g of 
soluble axonin-1, purified from vitreous fluid; lane 3, 0.2 #g of membrane-bound axonin-1 isolated by immunoaflinity chromatography 
from CHAPS-extracts of stripped brain membranes; lane 4, 100#g of CHAPS-extracted stripped brain membrane proteins. (B) Two- 
dimensional immunoblots with monoclonal antibody HNK-1 and polyclonal anti-axonin-1 antibody. 3 #g of soluble axonin-I were resolved 
by two-dimensional SDS-PAGE, electrotransferred to nitrocellulose and subsequently stained with HNK-1 ( op) or anti-axonin-I antibodies 
(bottom). Note that all the isoelectric variants recognized by anti-axonin-I also bear the HNK-I epitope. 
Released Axonin-1 Is Derived from the 
Fast-Turnover Pool; the Slow-Turnover Pool Does Not 
Contribute Substantially 
To identify the form representing the pool of origin of released 
axonin-1, the slow-turnover and the fast-turnover forms were 
differentially abeled with [3H]leucine and [35S]methionine, 
respectively, by appropriately timed pulse-chase double- 
labeling, and the content in each isotope of both the cellular 
and the released form was determined (Fig. 7). Virtually ex- 
clusive labeling of the slow-turnover form was obtained with 
a long-lasting pulse of [3H]leucine (4 d) followed by a chase 
of 63 h (representing >10 half-lives of the fast-turnover form). 
Beginning after 63 h of chase, a pulse of [35S]methionine 
was given for 48 h. With this pulse duration, full labeling of 
the fast-turnover pool was obtained; the calculated labeling 
of the slow-turnover pool was "o20%. 
The radioactivity of [3H]leucine and [3~S]methionine found 
in cellular and released axonin-1, at various points in time 
during the pulse with [35S]methionine, is shown in Fig. 7 A. 
In accordance with the data revealed by the decay kinetics, 
the cellular form of axonin-1 displayed a biphasic ourse of 
isotope incorporation. A fast-saturating phase preceded a
period of virtually linear increase, interpreted to represent 
a slowly saturating second phase. Released axonin-1, after a 
short lag, had assumed a steady rate of release. An estima- 
tion of the relative contributions of each pool to released 
axonin-1 can be derived from a comparison of the rates of 
release with the respective pool sizes. The fast-turnover pool 
of axonin-1 contained, at saturation, "o2,000 cpm of [35S]- 
methionine. Between 11.5 and 48 h of the [35S]methionine 
pulse, the [35S]methionine-labeled fast-turnover pool had 
released 4,200 cpm of axonin-1, corresponding to a daily 
release of 2,800 cpm. Hence, "ol.4 times the content of the 
fast-turnover pool is released per day. In consideration of a 
half-life of 5.1 h, an estimated 60% of the throughput of the 
fast-turnover pool was recovered from the extracellular space. 
The slow-turnover pool of axonin-1 decreased from 3,300 to 
2,300 cpm between 63 and 111 h chase. Approximately 500 
cpm were recovered with axonin-1 accumulated in the super- 
natant during this 48-h period. Hence, the slow-turnover 
pool releases <10% of its content in a day. Based on these 
data, in conjunction with the ratio of the pool sizes deter- 
mined in the single-isotope pulse-chase studies, the esti- 
mated contribution of the fast-turnover pool to axonin-1 re- 
lease is ,o90%. 
The predominant origin of released axonin-1 from the fast- 
turnover pool is corroborated by the ratios of [35S]methio- 
nine to [3H]leucine labeling throughout this prolonged pulse 
of 48 h in both the cellular and the released axonin-1 (Table 
II). The ratio in cellular axonin-1 had assumed equivalence 
by the end of a 48-h pulse period, whereas the ratio in the 
released form had reached a value >10 at this point. Account- 
ing for the fact that the ratios for the released axonin-1 were 
derived from cumulative data obtained over the entire pulse 
period and show a clearly increasing tendency, the instan- 
taneous ratio in axonin-1 released at 48 h was estimated to 
be considerably higher. Since, under the conditions of this 
experiment, [3H]leucine labeling represents exclusively the 
slow-turnover pool and most of the [3~S]methionine is lo- 
cated in axonin-1 of the fast-turnover pool, these data clearly 
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Figure 6. Radioactive pulse-chase experiments reveal two kineti- 
cally distinct forms of axonin-l. The experimental conditions f r 
these studies were governed to a high degree by the life cycle of the 
DRG cultures used. Dissociated DRG neurons, when grown in the 
presence of 5-fluorodeoxyuridine, developed a dense meshwark of 
axons during the first 6-8 d in culture and thereafter ceased to grow
and passed into an apparently stationary period lasting for *10d. 
During this period, neuronal cell death was found not t  exceed 
20%. Thereafter, however, signs of progressive deterioration be- 
came evident. To work under the steady-state assumption, kinetic 
experiments had to be carried out between day 8 and day 18 in cul- 
ture. Starting atday 5 in culture, dissociated DRG neurons were 
pulsed for 6.5 d with 0.25 mCi [3H]leucine per milliliter. The 
medium was removed and cells were washed and chased. At each 
of the indicated time points of chase, the cells of three cultures were 
harvested after removal of the medium and axonin-I was isolated 
by immunoprecipitation, and analyzed by SDS-PAGE and fluorog- 
raphy. Bands corresponding to axonin-I were located in the gel by 
means of fluorography, cut out, and the radioactivity incorporated 
into axonin-I was determined by liquid scintillation counting. Each 
value was determined from triplicate cultures and the vertical bars 
represent standard deviation. 
identify the fast-turnover pool as the source of released 
axonin-l. 
The proportion of the fast-turnover pool devoted to release 
was evidenced uring the chase of a short duration (11,5 h) 
second pulse of [35S]methionine (Fig. 7 B). (After a pulse 
period of 11.5 h, ,x,6% of the slow-turnover pool (h/2 = 104 
h) is labeled, whereas the fast-turnover pool has reached 
*75 % of saturation.) The release of [35S]methionine-labeled 
axonin-1 during the [35S]methionine pulse (63-74.5 h) was 
1,243 cpm, i.e., approximately one-half of the estimated 
pool size of the fast-turnover pool (a lag period of a few hours 
precedes the period of a linear rate of release). In the two 
chase periods, the [35S]methionine released with axonin-1 
was between 70 and 80% of the quantity that had disap- 
peared from the cells: during the first chase of 23 h, 1,360 
cpm of pS]methionine had disappeared from the cellular 
axonin (i.e., the fast-turnover pool) and 1,120 cpm were 
released; during the second chase of 23 h, 260 cpm disap- 
peared from the cellular axonin-1 and 190 cpm were re- 
leased. These data are in good agreement with the 60% of 
the throughput to be attributed to release, as calculated from 
the data obtained during the 48-h [35S]methionine-pulse pe-
riod of the double-labeling experiment (Fig. 7 A). 
The Slow-Turnover Form Is Exposed at the Cell 
Surface, the Fast-Turnover Form Is Intracellular 
To assess whether there was extracellular exposure of either 
one of the kinetically identifiedforms,-externally ccessible 
proteins were covalently labeled by the addition of the amino 
group-reactive agent biotin-X-NHS to live cells, at time 0 h 
and time 64 h of chase after a 4-d pulse of [3H]leucine (Fig. 
8). I f  biotinylation was carried out immediately at the end 
of the pulse, ~25 % of the labeled axonin-1 was biotinylated. 
After a chase of 64 h, when the fast-turnover form had virtu- 
ally disappeared (cf. Fig. 6), ~45 % of the remaining slow- 
turnover form was biotinylated. The absolute amounts of bi- 
otinylated axonin-1 at time-points 0 h and 64 h were very 
similar. The complete disappearance of the fast-turnover 
form (the white area in the bar representing total axonin-1) 
between 0 h and 64 h of chase was not accompanied bya cor- 
responding reduction in biotinylated axonin-1; the slight de- 
crease of biotinylated axonin-1 at the later time-point fol- 
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Figure 7. Released axonin-1 is derived fromthe fast-turnover pool; 
the secretory pathway doesnot include the slow-turnover pool. (A) 
After a pulse with 0.25 mCi [3H]leucine per milliliter for 4 d and 
a chase of 63 h, DRG neurons were subjected to a second pulse with 
[3~S]methionine (0.25 mCi/ml) for 48 h. (D; t~H]~) [35H]leucine in 
cellular axnnin-1; (m; [3HI,) [3H]leucine in supernatant axonin-1; 
(zx; FsS]c) [35S]methionine i  cellular axonin-1; and (A; ['Sis) 
[3~S]methionine  supernatant axonin-l. Thearrow at 63 h indi- 
eates the beginning of the [35S]methionine pulse. (B) Same condi- 
tion as A, except that the second pulse with [35S]methionine was 
for 11.5 h, followed by two chase periods of 23 h. At the end of the 
[35S]methionine pulse and after each chase period, the culture 
medium of all cultures was harvested, the cells were washed, and 
fresh medium was added. The arrow at 63 h indicates the beginning 
of the [3SS]methionine pulse; arrows at74.5 h and 97.5 h indicate 
the beginning of the consecutive chase periods, respectively. ([]) 
[3H]leucine in cellular axonin-l; (zx) [~sS]methinnine in cellular 
axonin-1; (A) [35Slrnethionine i  supernatant axonin-1. The values 
indicated are the mean of triplicate measurements; the vertical ba s 
represent standard deviation. The curve for the released axonin-I 
during the first chase period (B) has been arbitrarily drawn for the 
sake of clarity. The initial slope has been taken from the slope of 
the release found at this time in the long time pulse of [35S]methio- 
nine (,4). 
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Table 11. Proportions of the Fast-Turnover and the 
Slow-Turnover Form in Cellular and Released Axonin-1 
Ratio 
([35Slmethionine/[3H]leueine) 
Time Cellular axonin- 1 Supernatant xonin- 1
mean 5: SEM mean 5: SEM 
Pulse with [35S]methionine 
3.5 h 0.38 + 0.04 2.2 + 0.1 
6 h 0.44 + 0.02 3.2 + 0.1 
11.5 h 0.81 -1- 0.02 4.5 + 0.2 
48 h 1.01 5:0.07 10.8 5:0.4 
Chase after 11.5-h pulse of 
[35Slmethionine 
23 h 0.26 + 0.02 4,6 5- 0.4 
47 h 0.17 + 0.01 1.1 5- 0.1 
DRG neurons were pulsed for 4 d with [3H]leucine. After a chase period of 
63 h, cells were pulsed with [35S]methionine for the time period indicated. 
The sapernatant d cells were harvested separately and axonin-1 was isolated 
by immunoprecipitation, f llowed by SDS-PAGE/fluorography. The cor- 
responding bands were cut out of the gels and the ratio of [3SS]methio- 
nine/[3H]leucine was determined byliquid scintillation counting. 
E 
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Figure 8. The slow-turnover 
form of axonin-1 is modified 
by externally added biotin-X- 
NHS, i.e., it is membrane sur- 
face exposed; the fast-turn- 
over form is protected from 
external biotinylation, a d is 
therefore presumed to be in-
tracellular. Cultures of dis- 
sociated DRG neurons were 
subjected to an extended pulse 
with 0.2 mCi [3H]leucine per 
milliliter (4 d), the superna- 
tant was removed an  the cells 
were chased. At the beginning 
of the chase period and after 
64 h, externally accessible 
proteins of the live cells were 
modified by reaction with bio- 
tin-X-NHS. Biotinylated and 
nonbiotinylated proteins were 
separated by chromatography 
on Streptavidin-agarose. Ax- 
onin-I of both fractions was 
immunoprecipitated and subjected to SDS-PAGE/fluorography. 
The bands corresponding toaxonin-I were located in the gels by 
means of the tluorographic replica and cut out ofthe gels. The con- 
tent of [3H]leucine in axonin-1 was determined by liquid scintilla- 
tion counting. The first bar at each time point represents he total 
radioactivity of cellular axonin-1. As a visual aid, the proportion 
of slow-turnover axonin-1 at both time points, as calculated based 
on pool sizes and turnover rates, is represented by the hatched area 
of the bar. The solid bar represents the radioactivity of axonin-I 
modified by external biotinylation and affinity purified by consecu- 
tive subjection to Streptavidin-agarose and immunoprecipitation. 
All experiments were carried out in triplicate; the vertical lines rep- 
resent SEM. As a control for the restriction of the labeling to exter- 
nally exposed proteins, cytosolic aspartate aminotransferase, an en- 
zyme of established cytosolic location (Behra et al., 1982), was 
included into he study. After exposure of cultured DRG neurons 
to external biotin-X-NHS, cytosolic aspartate aminotransferase was 
found to be free of biotin, thus confirming intracellular proteins to 
be protected from labeling. 
lowed the rate of disappearance of the slow-turnover form 
during this lapse of time. The fact that only ~45% ofaxonin- 
1 was biotinylated after 64 h of chase, when only the slow- 
turnover pool was radioactive, most likely is a matter of yield 
rather than evidence for two populations of slow-turnover 
axonin-1. An overall yield of 45 % appears reasonable for a 
procedure comprising a chemical modification of live cells 
in culture and two steps of affinity chromatographic puri- 
fication. The aforementioned data clearly demonstrate hat 
at least a substantial proportion of the slow-turnover form is 
exposed to the cell surface. The fact that the quantity of bio- 
tinylated axonin-1 was not higher at time 0 h of chase, when 
approximately equal quantities of both pools were present, 
indicates the fast-turnover form to be protected from biotiny- 
lation, and hence to be intracellular. 
Axonin-1 Released from the Fast-Turnover Pool Is Not 
Exposed on the Cell Surface before Release 
The origin (cell surface vs. intracellular) of released axonin-1 
was more directly investigated by external biotinylation of 
live cells after the second pulse in a pulse-chase double- 
labeling experiment. As shown in Table III, the released 
axonin-1 rapidly acquired [35S]methionine (the second la- 
bel) which became prevalent over [3H]leucine in <4 h of 
pulse, as concluded from the ratio of [35S]methionine/[3H] - 
leucine. The biotinylated, thus externally accessible, cellular 
axonin-1 showed delayed accumulation of [35S]methionine, 
the isotope ratio remaining strongly in favor of [3H]leucine, 
even after a 10-h pulse. In view of these data, the biotin- 
ylated, i.e., the cell surface xposed form of axonin-1, cannot 
be the source of released axonin-1. 
Considering that the measured [3sS]methionine/[3H]leu- 
cine ratios of released axonin-1 are derived from cumulative 
values obtained over the respective times of secretion, and 
knowing that the released form is derived from the fast- 
turnover pool, which in this labeling situation contains only 
[35S]methionine, the actual ratios of the cellular precursor 
pool of released axonin-1 at each time point is expected to 
be even higher, approaching the value of its precursor pool 
after a prolonged time, when the initial lag and saturation 
period becomes negligible. This prediction is fulfilled, if 
homogeneity of the slow-turnover pool with respect o cell 
surface xposure is assumed and the data of external biotiny- 
lation are corrected for incomplete reaction efficiency. In this 
case (Table UI, last column), the ratio of the released mate- 
rial is indeed below the corresponding ratio of the biotin-free 
axonin-1 at all time points, reaching a value close to half of 
the ratio of the intracellular (biotinylation protected) pool af- 
ter 10 h of pulse, when the labeling of the fast-turnover pool 
turns towards saturation. These data indicate a precursor- 
product relationship between the internal, fast-turnover pool 
and the released axonin-1. 
Soluble Axonin4 Is Quantitatively the Major Form 
In embryonic hicken brair~ membranes, axonin-1 had been 
found substantially less abundant han Ng-CAM (Fig. 4). 
Among the soluble proteins of the embryonic vitreous fluid, 
however, axonin-1 had outranked Ng-CAM by at least one or- 
der of magnitude. This observation suggested the major 
proportion of axonin-1 to be in solution and only a relatively 
small fraction to ccur in membrane-bound form. To obtain 
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Table IlL External Biotinylation of DRG Neurons during l~SS]Methionine Pulse of [~H]Leucine Pulse-chased 
Dissociated Cultures 
Duration of 
[35S]methionine Form of [35S] Methionine/[3H]leucine 
pulse axonin- 1 [35S]Methionine/[3Hlleucine corrected 
h mean -I- SEM 
1 Cellular, biotin- 0.47 5:0 .02 
biotin + 0.02 5:0.002 
Supernatant 0 
4 Cellular, biotin- 
biotin + 
Supernatant 
10 Cellular, biotin- 
biotin + 
Supernatant 
2.1 
0.02 
0 
1.2 5:0.1 3.2 
0.38 5:0 .02 0.38 
1.3 5:0.1 1.3 
1.9 + 0.3 8.9 
0.7 + 0.1 0.7 
4.2 5 :0 .3  4.2 
DRG neurons were pulsed for 4 d with 0.25 mCi [3H]leucine per milliliter. After a chase for 63 h, [3SS]methionine (0.2 mCi/ml) was added for the time periods 
indicated. After collecting the supernatant, externally accessible proteins of the live cells were modified by reaction with biotin-X-NHS for 2 rain. Subsequently, 
the cells were washed and lysed. The cellular proteins were subdivided into a biotinylated (i.e., xtracellularly exposed) and a nonbiotinylated (i.e., intracellular) 
fraction by affinity chromatography on Streptavidin-agarose. From both fractions, axonin-I was isolated by immunoprecipitation, f llowed by SDS-PAGE/fluorog- 
raphy. Corresponding bands were cut out of the gels, rehydrated, and the [3~S]methionine/[3H]leucine ratiowas determined by liquid scintillation counting. In 
the last column, nonbiotinylated fractions were corrected for the efficiency of this modification-reaction (yield 53%). 
a quantitative stimation on the ratio of soluble and 
membrane-bound axonin-1, the vitreous fluid and the retina 
of 14-d chicken embryos were investigated for their content 
in axonin-1. Using ELISA, ',~50 ng of axonin-1 were found 
in the retina, whereas between 1.2 and 2 #g of soluble 
axonin-1 were present in the vitreous fluid. As a conservative 
estimate, assuming a constant rate of accumulation between 
embryonic day 6 and 14 and the absence of degradation, the 
daily secretion of axonin-1 into the vitreous cavity corre- 
sponds to approximately five times the amount of the axonin- 
1 present in the retinal tissue, the estimated throughput ofthe 
secretory pool in the retina being at least three times higher 
than in the in vitro experiments with embryonic DRG neu- 
rons. These in vivo data confirm the evidence obtained from 
previous in vitro studies (Stoeckli et al., 1989; Ruegg et at., 
1989; this paper) that the soluble form of the extracellular 
space is quantitatively predominant and that only a minor 
proportion of axonin-1 is found in cell association. Such a 
quantitative predominance of the soluble over the membrane- 
associated form in both total quantity and rate of production 
is unprecedented for cell adhesion molecules reported to 
date. 
Discussion 
Membrane-associated Axonin-1, by Operational and 
Structural Criteria, Is a Cell Adhesion Molecule 
A membrane-associated homologue of the axonally secreted 
protein axonin-1 has been identified. By its predominant lo- 
cation in nerve fiber tracts, axonin-1 appears closely related 
to the neural cell adhesion proteins of the L1/nerve growth 
factor-inducible large external glycoprotein (NILE)/Ng- 
CAM/G4/8D9-group, Fll, and neurofascin, which, because 
of their common topographic restriction in their expression 
pattern, recently have been gathered under the denomination 
AxCAM (Rutishauser and Jessel, 1988). In its occurrence in
nerve fiber tracts, axonin-1 overlaps with N-CAM, which 
however, is found in many other areas of the nervous ystem 
too (Daniloff et al., 1986). Addition of anti-axonin-1 Fab 
fragments o cultured orsal root ganglia during the time of 
axon growth resulted in alterations in the fasciculation pat- 
tern, which closely corresponded to those evoked with 
anti-N-CAM Fab fragments (Rutishauser t al., 1978) and 
have recently been observed in the presence of antibodies to 
a number of AxCAMs, namely NILE (StaUcup and Beasley, 
1985), L1 (Fischer et al., 1986), Ng-CAM (Friedlander et 
al., 1986), G4 and Fll (Rathjen et at., 1987a), and neurofas- 
cin (Rathjen et at., 1987b). All AxCAMs, as well as N-CAM, 
have been reported to be membrane proteins, which exert 
their adhesive function by the binding of their surface-ex- 
posed portion to appropriate ligands of adjacent cell mem- 
branes. In accordance with this concept, anti-axonin-1 Fab 
fragments were indeed located at the axonal surface at the 
end of the fasciculation perturbation experiment, implying 
axonin-I contributions to fasciculation i  a membrane-as- 
sociated state. By the facts that it is situated in axonal mem- 
branes, exposed to the axonal surface, and its specific anti- 
bodies perturb fasciculation, membrane-bound axonin-1 
fulfills the operational definition of a cell adhesion molecule 
(Frazier and Glaser, 1979; Rutishauser and Jessel, 1988). 
Besides meeting operational criteria for a cell adhesion 
molecule, axonin-1 also expresses the L2/HNK-1 and the L3 
epitope carbohydrate structures shared by a number of Ax- 
CAMs and other Ca2+-independent adhesion molecules 
(Schachner, 1989). The underlying carbohydrate structures 
have been proposed to represent family traits of adhesive 
molecules (Kruse et al., 1984; Kiicherer et al., 1987), and, 
recently, evidence for their direct participation as ligands in 
the adhesive interaction has been presented (Kiinemund et 
al., 1988; Schachner, 1989). These structural features, in 
conjunction with its topographical location and its opera- 
tional qualification as a cell adhesion molecule, justifies a 
bona fide assignment of axonin-1, in its membrane-bound 
form, to the AxCAMs. 
The nature of the membrane association of axonin-1 was 
investigated bymembrane subfractionation studies. Prepara- 
tions of embryonic brain membranes were subjected to 
Ruegg et al. Axonin-I Is Involved in Neurite Fasciculation 2375 
procedures designed for the release of vesicle-trapped solu- 
ble proteins (ultmsonication), removal of peripheral mem- 
brane proteins (high salt and high pH), and the solubilization 
of integral membrane proteins (CHAPS). A minor propor- 
tion of axonin-1 was found in a vesicle-enclosed form, possi- 
bly representing the content of secretory vesicles that had 
copurified with the plasma membranes. The peripheral 
membrane proteins were solubilized in two fractions by con- 
secutive application of two release procedures of different 
harshness, toestimate the relative strength of membrane at- 
tachment ofaxonin-1. Exposure to high salt, a relatively mild 
extraction procedure, was followed by the markedly harsher 
exposure to high pH (Steck and Yu, 1973; Fujiki et al., 
1982). In combination, these procedures removed about 
one-third (37 %) of axonin-1 from the sonicated membranes. 
The remaining axonin-1 was found releasable by subsequent 
exposure to CHAPS, and hence operationally qualified as an 
integral membrane protein. The data on absolute and specific 
contents of axonin-1 in the brain membrane subfractions 
reflected a discontinuity in the strength of membrane associ- 
ation. (a) The specific oncentration f axonin-1 in the pro- 
teins solubilized by the relatively mild high-salt procedure 
was more than twofold higher than in the material removed 
by the clearly harsher high pH condition, a fact which indi- 
cates this form of axonin-1 to be among the peripheral mem- 
brane proteins with a relatively weak membrane attachment. 
(b) Among the proteins resistant to high pH release and only 
extractable by CHAPS, the specific concentration of axo- 
nin-1 was >12-fold higher than among the high pH-released 
proteins, indicating this form to be among the most tightly 
bound membrane proteins. Therefore, with respect to the rel- 
ative strength of membrane attachment, a very weakly bound 
peripheral membrane form of axonin-1 is clearly distinct 
from an integral membrane form with a very strong mem- 
brane association. 
The integral membrane form of axonin-1 was compared 
with the soluble form by physicochemical, immunological, 
and protein-chemical criteria. The fact that the soluble and 
the integral membrane forms of axonin-1 are identical with 
respect o their isoelectric variant patterns, show complete 
fusion of their precipitin lines in the Ouchterlony double- 
diffusion test, and generate highly similar peptide patterns 
upon partial proteolytic cleavage, indicate avery high degree 
of structural similarity. However, a distinct difference in the 
relative migratory distance was observed on SDS-PAGE. 
The membrane-associated form characterized asan integral 
membrane protein displayed a lower apparent molecular 
mass than its soluble counterpart. The identity of the anti- 
genic determinants and the identity of all but one out of 26 
proteolytic peptides, suggests hat the difference in the elec- 
trophoretic migration rate may result from a localized struc- 
tural difference of two otherwise identical proteins. A differ- 
ence in the length of the polypeptide chain at either end of 
the molecule is a conceivable xplanation but also a local 
difference arising from posttranslational modification may 
be considered. The molecular mass difference was main- 
tained after enzymatic removal of N-linked glycans, indi- 
cating the underlying structural difference otto reside in 
N-linked carbohydrate. The qualification of a protein as an 
integral membrane protein based on resistance tosolubiliza- 
tion by high salt or high pH is operational nd hence, no con- 
clusions on the nature of the membrane attachment are possi- 
ble. The apparent molecular mass of the membrane-bound 
form being smaller than that of soluble axonin-1, membrane 
anchorage by covalently attached lipid is conceivable (Fergu- 
son and Williams, 1988). 
The Soluble Form of Axonin-1 Is Not Derived from 
the Membrane Form, but Directly Secreted from an 
lntraceUular Pool; As a Soluble Molecule Interacting 
with Adhesion Receptors, It Might Modulate 
Adhesive Interactions 
Cell adhesion molecules, by definition, are considered toex- 
ert their function i  membrane-association, h wever, a pos- 
sible role in solution has been suggested by the observation 
of soluble forms of N-CAM (Thiery et al., 1977; Goridis et 
al., 1978; Rohrer and Schachner, 1980) and NILE (Salton 
et al., 1983; Stallcup et al., 1983; Sweadner, 1983) in the 
conditioned media of neuronal cultures. The release of NILE 
(which is the rat homologue to L1, Ng-CAM, G4, and 8D9; 
Rutishauser and Jessel, 1988) and of another cell surface 
glycoprotein, possibly corresponding to N-CAM, was found 
to be evoked or enhanced by conditions which favor transmit- 
ter secretion and the mechanism of release was investigated 
(Sweadner, 1983). Shedding from the cell surface rather 
than classical secretion was found to underly this protein re- 
lease, as evidenced by the fact that the released form was 
found to be derived from a higher molecular weight, 
membrane-bound, and surface exposed precursor (Swead- 
net, 1983). Soluble axonin-1, in contrast, is not exposed to 
the cell surface before its release, but directly originates from 
an intracellular pool. This observation speaks in favor f 
classical secretion after packaging into secretory vesicles as 
the mechanism of release. 
Dualistic expression of a protein in a secreted and a 
membrane-bound form has previously been observed, e.g., 
with immunoglobulins (Cushley et al., 1982) and muscle 
acetylcholinesterase (Rotundo and Fambrough, 1980). Se- 
creted acetylcholinesterase, in accordance with our present 
findings on secreted axonin-l, was also derived from a rap- 
idly turning-over, intracellular pool, and, as membrane- 
bound axonin-1, the membrane-inserted form of the esterase 
had a markedly longer half-life (Rotundo and Fambrough, 
1980). Whether both secreted and membrane-bound axonin- 
1 are expressed by the same cell at the same time, and 
whether there is independent regulation of their expression, 
remains to be determined. 
Secreted axonin-1 occurs in relatively high concentrations 
in embryonic erebrospinal fluid and vitreous fluid (Ruegg 
et al., 1989) and, with respect o the overall abundance in
the central nervous ystem, is clearly the prevalent form. 
This is in notable contrast to the distribution of the other cell 
adhesion molecules that were investigated in this respect, 
namely N-CAM or Ng-CAM, where the major proportion 
is membrane associated and only trace amounts can be de- 
tected in solution (Fig. 4, A-C). Although a functional role 
of secreted axonin-I has not been determined thus far, the 
molecule carries features that suggest it to have adhesive 
properties. (a) Secreted axonin-I is structurally very similar 
to its membrane-bound homologue, which is involved in 
neurite fasciculation. (b) The antibodies evoking the ob- 
served alterations i  the fasciculation pattern, have been 
raised against the soluble antigen. Hence, the structure un- 
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derlying the antibody perturbation effect seems to be ex- 
pressed on both forms. (c) As its membrane-bound homo- 
logue, secreted axonin-1 carries both the L2/HNK-1 and the 
L3 epitopes. 
The possibility of cell adhesive properties on a soluble gly- 
coprotein secreted from axons during neurogenesis en- 
courages speculation about its functional role. Depending on 
its molecular configuration, a soluble adhesion molecule 
may have inverse functions. By binding in a soluble monova- 
lent form to a cell surface or ECM receptor, it could effect 
inhibition of cell adhesion, whereas in a bivalent form, it 
could act as a cross-linker between membranes or between 
membranes and the ECM, hence promoting cell adhesion. 
In the light of these suppositions, the membrane surface-ad- 
sorbed form of axonin-1 (released by high salt and high pH) 
could be interpreted to represent receptor-bound soluble 
axonin-1. The adventitious trapping of soluble axonin-1 from 
the extracellular fluid during the membrane preparation 
process cannot be xcluded on the basis of the currently 
available data, and therefore, unequivocal identification and 
localization of in vivo membrane surface-bound secreted 
axonin-1 by immunohistocbemical st ining in tissue sections 
is necessary. Yet, as a working hypothesis, it seems reason- 
able to assume that the intense staining along nerve fiber 
tracts reflects the integral membrane form, because this form 
represents he quantitatively major form of axonin-1 found 
in membranes. Since virtually all reported observations lo- 
cate the site of axonal protein secretion to the axon tip (Kelly, 
1988), the peripherally adsorbed form of membrane-associ- 
ated axonin-1 may occur in areas of high growth cone densi- 
ties. Appropriate binding sites provided, high local concen- 
trations in the narrow extracellular space in proximity of the 
site of release would favor preferential binding to cell sur- 
faces and/or ECM. Staining of the inner plexiform layer of 
the retina (Fig. 1 C) with its high density of growth cones 
at this stage of development represents an intriguing observa- 
tion in this context, as it could reflect secreted axonin-1. Both 
ultrastructural localization of the site of axonin-1 secretion 
from growth cones of elongating axons and its extracellular 
location will be necessary to test this hypothesis. Further 
studies will also include investigations on the ligand function 
of axonin-1 and its role in neural development. Preparative 
efforts to produce sufficient quantities of pure axonin-1 for 
studies towards this goal, are currently in progress in our lab- 
oratory. 
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